Chronic Venous Disease
1
Pipeline Programs
4
Companies
3
Clinical Trials
0
Approved Products
Pipeline by Development Stage
Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
1
Early DiscoveryClinical DevelopmentMarket
Competitive Landscape
3 companies ranked by most advanced pipeline stage
ServierFrance - Suresnes
1 programto estimate Sensitivity and Specificity AIVARIX app in detecting C1 and C2 classes of CVDN/A1 trial
Active Trials
Trial Timeline
Clinical trial activity over time
2021
2022
2023
2024
2025
2026
2027
2028
2029
Hanlim PharmEntelon Tab.150mg
InterVenemechanical thrombectomy
Servierto estimate Sensitivity and Specificity AIVARIX app in detecting C1 and C2 classes of CVD
Clinical Trials (3)
Total enrollment: 797 patients across 3 trials
Phase 4 Study to Evaluate Efficacy and Safety of Entelon Tab.150mg in Patients With Chronic Venous Disease(CVD)
Start: Jan 2021Est. completion: Feb 2022278 patients
Phase 4Unknown
The ReCAna for Lower ExtremIty Venous OBstructions and In-StEnt Restenosis Registry
Start: Jun 2026Est. completion: Mar 202986 patients
N/ANot Yet Recruiting
NCT05612217Servierto estimate Sensitivity and Specificity AIVARIX app in detecting C1 and C2 classes of CVD
Evaluation of the AIVARIX in Detecting Signs C 1-2 Classes of CVD
Start: Dec 2022Est. completion: Apr 2024433 patients
N/ACompleted
Phase Legend
Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available
Key Insights
4 companies competing in this space
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.